Apotea AB (publ) (STO:APOTEA)
Sweden · Delayed Price · Currency is SEK 64.95
+0.10 (0.15%)
At close: Apr 14, 2026
Apotea AB Market Cap
Apotea AB has a market cap or net worth of 6.76 billion as of April 14, 2026. Its market cap has decreased by -12.48% in one year.
Market Cap
6.76B
Enterprise Value
7.08B
Revenue
7.21B
Ranking
n/a
PE Ratio
29.56
Stock Price
64.95
Market Cap Chart
Since December 6, 2024, Apotea AB's market cap has decreased from 8.63B to 6.76B, a decrease of -21.68%. That is a compound annual growth rate of -16.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 14, 2026 | 6.76B | -29.57% |
| Dec 30, 2025 | 9.60B | 9.72% |
| Dec 30, 2024 | 8.75B | 1.35% |
| Dec 6, 2024 | 8.63B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 140.41B |
| Getinge AB | 52.28B |
| Sectra AB | 45.32B |
| Camurus AB | 30.74B |
| Ambea AB | 11.25B |
| Dynavox Group AB | 9.28B |
| Synsam AB | 9.26B |
| Xvivo Perfusion AB | 8.32B |